3 Biotech Impact Factor, Indexing, Ranking 2024

3 Biotech publishes the results of the latest research related to the study and application of biotechnology to:- Medicine and Biomedical Sciences- Agriculture- The EnvironmentThe focus on these three technology sectors recognizes that complete Biotechnology applications often require a combination of techniques. 3 Biotech not only presents the latest developments in biotechnology but also addresses the problems and benefits of integrating a variety of techniques for a particular application. 3 Biotech appeals to scientists and engineers in both academia and industry focusing on the safe and efficient application of Biotechnology to Medicine, Agriculture and the Environment.Articles from a huge variety of biotechnology applications are welcome including:- Cancer and stem cell research- Genetic engineering and cloning- Bioremediation and biodegradation- Bioinformatics and system biology- Biomarkers and biosensors- Biodiversity and biodiscovery- Biorobotics and biotoxins- Analytical biotechnology and the human genome3 Biotech accepts original and review articles as well as short research reports, protocols and methods, notes to the editor, letters to the editor and book reviews for publication. Up to date topical review articles will also be considered. All the manuscripts are peer-reviewed for scientific quality and acceptance.3 Biotech has recently received its first Impact Factor and is now covered by a range of A&I services, including:- Science Citation Index Expanded- Journal Citation Reports/Science Edition- Biological Abstracts- BIOSIS Previews3 Biotech publishes under the Continuous Article Publishing (CAP) in which accepted papers are published online with volume and article numbers shortly after receipt of authors proofs. CAP aims to speed up the process from acceptance of articles to final publication without the need for articles to be placed in a waiting line. This will ensure that all articles in 3 Biotech are immediately available for researchers in relevant indexing and abstracting databases.

3 Biotech 发表了与生物技术研究和应用相关的最新研究成果，涵盖以下三个技术领域：- 医学和生物医学科学- 农业- 环境。对这三个技术领域的关注体现了完整生物技术应用通常需要多种技术的结合。3 Biotech 不仅展示了生物技术的最新进展，还探讨了针对特定应用整合多种技术的利弊。3 Biotech 吸引了学术界和工业界专注于生物技术在医学、农业和环境中的安全高效应用的科学家和工程师。欢迎来自各种生物技术应用领域的文章，包括：- 癌症和干细胞研究- 基因工程和克隆- 生物修复和生物降解- 生物信息学和系统生物学- 生物标志物和生物传感器- 生物多样性和生物发现- 生物机器人和生物毒素- 分析生物技术和人类基因组。3 Biotech 接受原创文章、综述文章、简短研究报告、方法协议、编辑笔记、编者来信和书评的投稿。同时，还将考虑最新的主题综述文章。所有稿件均经过同行评审以确保科学质量和接受度。3 Biotech 最近获得了其首个影响因子，并已被包括科学引文索引扩展版（Science Citation Index Expanded）、期刊引证报告/科学版（Journal Citation Reports/Science Edition）、生物学文摘（Biological Abstracts）和BIOSIS 预览在内的多种A&I服务收录。3 Biotech 采用连续文章出版（Continuous Article Publishing，简称CAP）模式，即在收到作者校样后，接受的文章将在线发布，并带有卷号和文章号。CAP 的目的是加快从文章接受到最终出版的过程，无需将文章置于等待队列中，从而确保3 Biotech 中的所有文章都能立即供相关索引和文摘数据库中的研究人员使用。